Khalil Helzy
YOU?
Author Swipe
View article: Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation
Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation Open
These results do not support the hypothesis that calreticulin-mutated platelets have platelet function defects that could explain the lower thrombotic risk of patients with CALR.